PN

Pareshkumar Narottambhai Patel

Active Director Additional Director DIN 07983332
DIN 07983332 First appointment Nov 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Nov 2017
Shareholding value •••• Premium profile

About Pareshkumar Narottambhai Patel

Data last updated:

Pareshkumar Narottambhai Patel is an Additional Director at Integrity Pharmachem Private Limited (since 2021), Additional Director at Integrity Formulations Private Limited (since 2024) and Director at Igt Pharma Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹54.74 Cr; the largest is Integrity Pharmachem Private Limited at ₹35.33 Cr (FY 2025). Earlier, Pareshkumar Narottambhai Patel was a Director at Atmichem Industries Private Limited (2017–2020).

DIN 07983332
Primary Designation Additional Director
Industry Pharma
First Appointment 07 Nov 2017
Oldest Company Age 5 yrs
Largest company Integrity Pharmachem Private Limited · ₹35.33 Cr (FY 2025)
Combined revenue ₹54.74 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Integrity Pharmachem Private Limited U24110GJ2021PTC119867
Additional Director10 May 20212021₹35.33 Cr (FY 2025)Active
Additional Director15 Oct 20242021₹12.80 Cr (FY 2025)Active
Igt Pharma Private Limited U24230GJ2022PTC132283
Director24 May 20222022₹6.60 Cr (FY 2024)Active
Integrity Solochem Private Limited U46497GJ2024PTC151121
Director29 Apr 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atmichem Industries Private Limited U24100GJ2015PTC081884
Director07 Nov 20172015₹31.4 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Pareshkumar Narottambhai Patel

Directorship timeline

Open interactive timeline →
Integrity Pharmachem Private Limited
Igt Pharma Private Limited
Integrity Formulations Private Limited
Integrity Solochem Private Limited
Premium access

Shareholding and investment profile for Pareshkumar Narottambhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pareshkumar Narottambhai Patel

Pareshkumar Narottambhai Patel currently holds 4 directorships: Integrity Pharmachem Private Limited (Additional Director, since 10 May 2021, revenue ₹35.33 Cr (FY 2025)); Integrity Formulations Private Limited (Additional Director, since 15 Oct 2024, revenue ₹12.80 Cr (FY 2025)); Igt Pharma Private Limited (Director, since 24 May 2022, revenue ₹6.60 Cr (FY 2024)); Integrity Solochem Private Limited (Director, since 29 Apr 2024).

Pareshkumar Narottambhai Patel was first appointed on 07 Nov 2017 as Director at Atmichem Industries Private Limited. The most recent appointment on record is 15 Oct 2024 at Integrity Formulations Private Limited.

The 3 current companies of Pareshkumar Narottambhai Patel that report revenue have a combined latest revenue of ₹54.74 Cr: Integrity Pharmachem Private Limited ₹35.33 Cr (FY 2025); Integrity Formulations Private Limited ₹12.80 Cr (FY 2025); Igt Pharma Private Limited ₹6.60 Cr (FY 2024).

Pareshkumar Narottambhai Patel held 1 earlier board appointment: Atmichem Industries Private Limited (Director, 07 Nov 2017 to 17 Aug 2020).

The current boards of Pareshkumar Narottambhai Patel's companies include Upasna Dipesh Thakkar (Integrity Pharmachem Private Limited), Alkaben Sureshbhai Thakkar (Integrity Formulations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available